Privia Health Group, Inc.
PRVA Healthcare Health Information Services
Privia Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 22.3% from fiscal 2024. In the quarter to June 2026, revenue grew 21.4%, EPS grew 250.0% and free cash flow fell 86.2%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
Follow PRVA
Privia Health Group, Inc. (PRVA) Altman Z-score
Privia Health Group, Inc.'s Altman Z-score for fiscal 2025 is 4.78, in the safe zone (above 2.99).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2025 | 4.78 | (0.08) |
| FY2024 | 4.86 | (1.08) |
| FY2023 | 5.94 | (1.25) |
| FY2022 | 7.19 | 0.04 |
| FY2021 | 7.15 | — |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | 0.25 | — | 0.30 | |
| Retained earnings / total assets | (0.11) | — | −0.16 | |
| EBIT / total assets | 0.03 | — | 0.08 | |
| Market value of equity / total liabilities | 5.01 | — | 3.00 | |
| Sales / total assets | 1.55 | — | 1.55 | |
| Altman Z-score | Safe zone | 4.78 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Safe zone | 2.87 | ||
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| DOCS Doximity, Inc. compare | 17.1× |
| HTFL Heartflow, Inc. compare | 7.2× |
| PRVA Privia Health Group, Inc. | 4.8× |
| OMDA Omada Health, Inc. compare | 4.0× |
| OMCL Omnicell, Inc. compare | 2.7× |
| WAY Waystar Holding Corp. compare | 2.2× |
| CERT Certara, Inc. compare | 2.0× |
| SDGR Schrodinger, Inc. compare | 1.1× |
| GDRX GoodRx Holdings, Inc. compare | 0.4× |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets